Ann: Chimeric receives US patent covering CLTX CAR technology, page-22

Why not then just sell and bank the capital loss to offset any other winners?
What possible benefit does bashing the stock now do?

You can either a) buy more and average down. (Many here have done this)
b) Sell and move on.
c) Continue to play the micro cap ASX biotech wheel of patience and see if the science pans out.

On interesting point, CHM has actually dropped far less than many others have been watching and since mid November is following the same market sell off as all others.

I am keen to find out when we will get the data read out for cohort 2 as this will be very interesting to look at the impact of dual dosing methods. And if history is anything to go by the timeframe should align nicely with next major Cancer Conference.